Home News and Analysis Deals & Exits

Deals & Exits

These investors have piled money into the industry over the last 10 years, and in the midst of a pandemic aren’t pulling back or going anywhere.
Co-founder and CEO Matt Crisp said the mix of investors is a deliberate effort to help its base form a holistic view of change within global food and ag supply chains.
VC investment into agtech has grown 75% since 2014 and looks keen to keep growing as the sector offers opportunities across types of investors.
The well-known VC and blogger discusses the reasons public markets may be willing to pay more for high-growth companies and how this impacts early-stage cloud start-ups.
More than $273m has gone into the sector so far in 2020, already surpassing the full-year totals of four of the last five years.
Biotech VCs have played a crucial role in developing medicines for the disorder before selling them to big pharma, and they've realized exceptional returns while making a difference in patients' lives.
Reports tell a different story than personal anecdotes, but it seems like there's no letup in 2020 for venture fundraising and deployment during a pandemic.
Healthcare Money
Bernard Ross of Sky Medical Technology says that the European medtech market has grown in recent years and he expects it to keep rising since the region is ripe with innovation.
Mercato Partners co-founder Greg Warnock talks about the firm’s growth strategy and the impact of racking up four exits since April.
Matt McCooe of Connecticut Innovations writes that the stereotypical successful tech entrepreneur is not a nerdy white guy in jeans from Silicon Valley. Investors need to broaden their lens.

Copyright PEI Media

Not for publication, email or dissemination